Back to Search Start Over

Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.

Authors :
Korthuis PT
Hoffman K
Wilson-Poe AR
Luoma JB
Bazinet A
Pertl K
Morgan DL
Cook RR
Bielavitz S
Myers R
Wolf RC
McCarty D
Stauffer CS
Source :
Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2024 Aug; Vol. 38 (8), pp. 761-768. Date of Electronic Publication: 2024 Jun 18.
Publication Year :
2024

Abstract

Background: Voter initiatives in Oregon and Colorado authorize legal frameworks for supervised psilocybin services, but no measures monitor safety or outcomes.<br />Aims: To develop core measures of best practices.<br />Methods: A three-phase e-Delphi process recruited 36 experts with 5 or more years' experience facilitating psilocybin experiences in various contexts (e.g., ceremonial settings, indigenous practices, clinical trials), or other pertinent psilocybin expertise. Phase I, an on-line survey with qualitative, open-ended text responses, generated potential measures to assess processes, outcomes, and structure reflecting high quality psilocybin services. In Phase II, experts used seven-point Likert scales to rate the importance and feasibility of the Phase I measures. Measures were priority ranked. Qualitative interviews and analysis in Phase III refined top-rated measures.<br />Results: Experts ( n  = 36; 53% female; 71% white; 56% heterosexual) reported currently providing psilocybin services (64%) for a mean of 15.2 [SD 13.1] years, experience with indigenous psychedelic practices (67%), and/or conducting clinical trials (36%). Thematic analysis of Phase I responses yielded 55 candidate process measures (e.g., preparatory hours with client, total dose of psilocybin administered, documentation of touch/sexual boundaries), outcome measures (e.g., adverse events, well-being, anxiety/depression symptoms), and structure measures (e.g., facilitator training in trauma informed care, referral capacity for medical/psychiatric issues). In Phase II and III, experts prioritized a core set of 11 process, 11 outcome, and 17 structure measures that balanced importance and feasibility.<br />Conclusion: Service providers and policy makers should consider standardizing core measures developed in this study to monitor the safety, quality, and outcomes of community-based psilocybin services.<br />Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Details

Language :
English
ISSN :
1461-7285
Volume :
38
Issue :
8
Database :
MEDLINE
Journal :
Journal of psychopharmacology (Oxford, England)
Publication Type :
Academic Journal
Accession number :
38888164
Full Text :
https://doi.org/10.1177/02698811241257839